Paediatric hip - Ultrasound screening for developmental dysplasia of the hip

A review

Paolo Tomà, Maura Valle, Umberto Rossi, Giorgio Marré Brunenghi

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

This paper will try to deal with the following questions: Which is the correct screening model for the developmental dysplasia of the hip (DDH)? What is the clinical significance of 'sonographic' DDH? Can overtreatment produced by ultrasound (US) screening cause a waste of resources and eventually morbidity? We reviewed the literature since January, 1996 through December, 2000. To compare our experience with the literature, we analysed the results of the US examinations of the hip performed in our Institute. Over 4 years of US screening 11 326 infants (22 652 hips), aged 3 days to 4 months, were examined consecutively. Sonographic hip findings were abnormal in 531 infants (4.7%). The screening showed 381 subjects (3.36% of the population) with a type IIa hip (bilateral or unilateral); 65% of these infants were normal at follow up and only 35% worsened. On the whole we treated 282 infants (2.5%). No open reduction was performed. Avascular necrosis appeared in 2/282 treated cases (1.06%). We support the routine generalised US screening of neonatal hips. The excess of doubtful cases and, consequently, of the extra referrals may be limited, and the overtreatment decreased to the lowest rates reported by optimisation of everyone's approach.

Original languageEnglish
Pages (from-to)45-55
Number of pages11
JournalEuropean Journal of Ultrasound
Volume14
Issue number1
DOIs
Publication statusPublished - 2001

Fingerprint

Hip Dislocation
Pediatrics
Hip
Screening
screening
Ultrasonics
Neonatal Screening
necrosis
resources
Necrosis
Referral and Consultation
examination
Morbidity
optimization
causes
Population

Keywords

  • Developmental dysplasia
  • Paediatric hip
  • Ultrasound screening

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Bioengineering
  • Acoustics and Ultrasonics
  • Chemical Engineering(all)

Cite this

Paediatric hip - Ultrasound screening for developmental dysplasia of the hip : A review. / Tomà, Paolo; Valle, Maura; Rossi, Umberto; Brunenghi, Giorgio Marré.

In: European Journal of Ultrasound, Vol. 14, No. 1, 2001, p. 45-55.

Research output: Contribution to journalArticle

Tomà, Paolo ; Valle, Maura ; Rossi, Umberto ; Brunenghi, Giorgio Marré. / Paediatric hip - Ultrasound screening for developmental dysplasia of the hip : A review. In: European Journal of Ultrasound. 2001 ; Vol. 14, No. 1. pp. 45-55.
@article{472bbbb2ae394046a024469a92d24c2c,
title = "Paediatric hip - Ultrasound screening for developmental dysplasia of the hip: A review",
abstract = "This paper will try to deal with the following questions: Which is the correct screening model for the developmental dysplasia of the hip (DDH)? What is the clinical significance of 'sonographic' DDH? Can overtreatment produced by ultrasound (US) screening cause a waste of resources and eventually morbidity? We reviewed the literature since January, 1996 through December, 2000. To compare our experience with the literature, we analysed the results of the US examinations of the hip performed in our Institute. Over 4 years of US screening 11 326 infants (22 652 hips), aged 3 days to 4 months, were examined consecutively. Sonographic hip findings were abnormal in 531 infants (4.7{\%}). The screening showed 381 subjects (3.36{\%} of the population) with a type IIa hip (bilateral or unilateral); 65{\%} of these infants were normal at follow up and only 35{\%} worsened. On the whole we treated 282 infants (2.5{\%}). No open reduction was performed. Avascular necrosis appeared in 2/282 treated cases (1.06{\%}). We support the routine generalised US screening of neonatal hips. The excess of doubtful cases and, consequently, of the extra referrals may be limited, and the overtreatment decreased to the lowest rates reported by optimisation of everyone's approach.",
keywords = "Developmental dysplasia, Paediatric hip, Ultrasound screening",
author = "Paolo Tom{\`a} and Maura Valle and Umberto Rossi and Brunenghi, {Giorgio Marr{\'e}}",
year = "2001",
doi = "10.1016/S0929-8266(01)00145-8",
language = "English",
volume = "14",
pages = "45--55",
journal = "European Journal of Ultrasound",
issn = "0929-8266",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Paediatric hip - Ultrasound screening for developmental dysplasia of the hip

T2 - A review

AU - Tomà, Paolo

AU - Valle, Maura

AU - Rossi, Umberto

AU - Brunenghi, Giorgio Marré

PY - 2001

Y1 - 2001

N2 - This paper will try to deal with the following questions: Which is the correct screening model for the developmental dysplasia of the hip (DDH)? What is the clinical significance of 'sonographic' DDH? Can overtreatment produced by ultrasound (US) screening cause a waste of resources and eventually morbidity? We reviewed the literature since January, 1996 through December, 2000. To compare our experience with the literature, we analysed the results of the US examinations of the hip performed in our Institute. Over 4 years of US screening 11 326 infants (22 652 hips), aged 3 days to 4 months, were examined consecutively. Sonographic hip findings were abnormal in 531 infants (4.7%). The screening showed 381 subjects (3.36% of the population) with a type IIa hip (bilateral or unilateral); 65% of these infants were normal at follow up and only 35% worsened. On the whole we treated 282 infants (2.5%). No open reduction was performed. Avascular necrosis appeared in 2/282 treated cases (1.06%). We support the routine generalised US screening of neonatal hips. The excess of doubtful cases and, consequently, of the extra referrals may be limited, and the overtreatment decreased to the lowest rates reported by optimisation of everyone's approach.

AB - This paper will try to deal with the following questions: Which is the correct screening model for the developmental dysplasia of the hip (DDH)? What is the clinical significance of 'sonographic' DDH? Can overtreatment produced by ultrasound (US) screening cause a waste of resources and eventually morbidity? We reviewed the literature since January, 1996 through December, 2000. To compare our experience with the literature, we analysed the results of the US examinations of the hip performed in our Institute. Over 4 years of US screening 11 326 infants (22 652 hips), aged 3 days to 4 months, were examined consecutively. Sonographic hip findings were abnormal in 531 infants (4.7%). The screening showed 381 subjects (3.36% of the population) with a type IIa hip (bilateral or unilateral); 65% of these infants were normal at follow up and only 35% worsened. On the whole we treated 282 infants (2.5%). No open reduction was performed. Avascular necrosis appeared in 2/282 treated cases (1.06%). We support the routine generalised US screening of neonatal hips. The excess of doubtful cases and, consequently, of the extra referrals may be limited, and the overtreatment decreased to the lowest rates reported by optimisation of everyone's approach.

KW - Developmental dysplasia

KW - Paediatric hip

KW - Ultrasound screening

UR - http://www.scopus.com/inward/record.url?scp=0034843546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034843546&partnerID=8YFLogxK

U2 - 10.1016/S0929-8266(01)00145-8

DO - 10.1016/S0929-8266(01)00145-8

M3 - Article

VL - 14

SP - 45

EP - 55

JO - European Journal of Ultrasound

JF - European Journal of Ultrasound

SN - 0929-8266

IS - 1

ER -